WDR77 and cancer: The authors show also a positive correlation between the expression of MEP50/PRMT5 and that of GLI1 target genes in several HH-dependent cancers, and demonstrate that targeting of MEP50/PRMT5 complex may synergize with SMO inhibitors in suppressing cancer cell proliferation and invasion (Abe et al., 2019).